FDA Panel Narrowly Endorses AtriCure’s Synergy For A-Fib Ablation

FDA’s Circulatory System Devices panel narrowly endorsed an expanded indication last week for AtriCure’s Synergy ablation system to treat certain types of atrial fibrillation during open-heart surgery, despite concerns over safety issues and limited data.